Could vitamins a and B3 shield kidney transplant patients from skin cancer?
NCT ID NCT05702398
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tests whether taking vitamin A and nicotinamide (a form of vitamin B3) can safely raise blood levels in kidney transplant recipients who have had skin cancer. Thirty participants will take these vitamins or a placebo for six months. The goal is to see if this approach is feasible for a larger future study aimed at preventing skin cancer in this high-risk group.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Vitamin A (retinyl palmitate) and nicotinamide (vitamin B3)
What this could lead to
If successful, this could point toward a simple vitamin-based approach to help prevent skin cancer in kidney transplant recipients.
What could go wrong
This is a very early pilot study with only 30 participants, so results may not apply to everyone. It only checks blood levels, not whether skin cancer is actually prevented.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SKIN CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Rhode Island Hospital
RECRUITINGProvidence, Rhode Island, 02912, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••